HYDROXYMED

Owners

Goods & Services

Pharmaceutical preparations comprising hydroxychloroquine for use in targeting malignant cells by inhibiting drug resistance, improving chemotherapy cell penetration, potentiation of presentation of major histocompatibility complexes, intercalating directly into DNA; Pharmaceutical preparations comprising hydroxychloroquine for use in tempering severe systemic inflammatory responses to filoviruses through dysregulation of lysosomes and lysosomal pH through decreased production of tumor necrosis factor alpha and interferon; Pharmaceutical preparations comprising hydroxychloroquine for use in preventing toll-like receptor activation by binding directly to nucleic acids in the activation pathway and lowering the body's primary cell-mediated inflammatory response.